Skip to content

Extensive Peritoneal Lavage after Curative Gastrectomy for Gastric Cancer: a Randomized Controlled Trial (EXPEL Study)

Extensive Peritoneal Lavage after Curative Gastrectomy for Gastric Cancer: a Randomized Controlled Trial (EXPEL Study) - Extensive Peritoneal Lavage for Gastric Cancer (P3)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000031780
Enrollment
800
Registered
2018-03-21
Start date
2018-03-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Study arm: Extensive peritoneal lavage. The peritoneal cavity will be washed with 10 liters of normal saline (1 liter each cycle for 10 cycles). Control arm: Standard treatment. The peritoneal cavity

Sponsors

National University Hospital, Singapore
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients who have T3 (subserosal) or T4 (serosal) disease based on CT scan and intra-operative inspection with any N staging and M0 gastric cancer. 2.Patients planned for open or laparoscopic gastrectomy. 3.Patients undergoing gastrectomy with curative intent. 4.Lower age limit of research subjects 21 years old and upper age limit of 80 years old. 5.Ability to provide informed consent 6.Ability to come back for study visits throughout the 3 years duration after surgery 7.Patients are local residents

Exclusion criteria

Exclusion criteria: 1.Patients who undergo a palliative gastrectomy. 2.Patients who undergo a gastrectomy as emergency. 3.Vulnerable persons under age of 21. 4.Patients receiving neoadjuvant therapy. 5.Patients presented with life-threatening bleeding from tumour 6.ASA score of 4 & 5 7.Patients with another primary cancer within last 5 years 8.Patients with gross peritoneal and liver metastasis at surgery.

Design outcomes

Primary

MeasureTime frame
Overall survival

Secondary

MeasureTime frame
Disease free survival Peritoneal recurrence rate

Countries

Japan,Asia(except Japan)

Contacts

Public ContactProf. Jimmy So

National University Hospital, Singapore Department of Surgery

sursbyj@nus.edu.sg+65-6772-3191

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026